Breath-Actuated Bi-Directional Delivery Sets the Nasal Market on a New Course

OnDrug Delivery | OptiNose

Nasal drug delivery is already a thriving market but there is still a wide gap between what has been achieved in the past and what could be achieved were the full potential of this highly attractive administration route released. This article describes a technological breakthrough by OptiNose that has allowed the company to make that hitherto elusive step of achieving truly optimal nasal drug delivery. Compiled by ONdrugDelivery on behalf of OptiNose.